Fresh Rounds

BioLattice Ophthalmics, Inc, funding

BioLattice Ophthalmics, Inc,, a biotechnology company based in Philadelphia, PA (founded 2023), filed a Form D with the SEC on March 30, 2026 and reported $575K raised of a $2.5M offering.

Amount raised$575K
Offering size$2.5M
Filed with the SECMarch 30, 2026
First saleMarch 6, 2026
IndustryBiotechnology
SecuritiesEquity
LocationPhiladelphia, PA
Founded2023
Entity typeCorporation
Investors so far2
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Pennsylvania